EP3911337A4 - Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose - Google Patents
Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose Download PDFInfo
- Publication number
- EP3911337A4 EP3911337A4 EP20741114.1A EP20741114A EP3911337A4 EP 3911337 A4 EP3911337 A4 EP 3911337A4 EP 20741114 A EP20741114 A EP 20741114A EP 3911337 A4 EP3911337 A4 EP 3911337A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- treating onychomycosis
- petrolatum compositions
- petrolatum
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000010195 Onychomycosis Diseases 0.000 title 1
- 239000004264 Petrolatum Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940066842 petrolatum Drugs 0.000 title 1
- 235000019271 petrolatum Nutrition 0.000 title 1
- 201000005882 tinea unguium Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962793317P | 2019-01-16 | 2019-01-16 | |
| PCT/US2020/013959 WO2020150531A1 (fr) | 2019-01-16 | 2020-01-16 | Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP3911337A1 EP3911337A1 (fr) | 2021-11-24 |
| EP3911337A4 true EP3911337A4 (fr) | 2022-10-26 |
Family
ID=71613212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP20741114.1A Pending EP3911337A4 (fr) | 2019-01-16 | 2020-01-16 | Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP3911337A4 (fr) |
| JP (1) | JP2022522991A (fr) |
| BR (1) | BR112021014073A2 (fr) |
| CA (1) | CA3127052A1 (fr) |
| WO (1) | WO2020150531A1 (fr) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016126982A1 (fr) * | 2015-02-05 | 2016-08-11 | Marc Selner | Suspension de nano-vésicules ioniques et biocide préparé à partir d'une telle suspension |
| US20160271121A1 (en) * | 2015-03-16 | 2016-09-22 | Gavis Pharmaceuticals | Antifungal combination therapy |
| US20170333346A1 (en) * | 2015-06-19 | 2017-11-23 | Global Health Solutions Llc | Petrolatum-based delivery systems and for active ingredients |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1355699A (zh) * | 1999-04-16 | 2002-06-26 | 藤泽药品工业株式会社 | 抗真菌组合物 |
| JP2004083439A (ja) * | 2002-08-23 | 2004-03-18 | Ss Pharmaceut Co Ltd | 爪用抗真菌外用剤 |
| US8039494B1 (en) * | 2010-07-08 | 2011-10-18 | Dow Pharmaceutical Sciences, Inc. | Compositions and methods for treating diseases of the nail |
| WO2013149190A1 (fr) * | 2012-03-30 | 2013-10-03 | Wu Nian | Compositions pharmaceutiques et méthodes pour le traitement d'infections fongiques |
-
2020
- 2020-01-16 EP EP20741114.1A patent/EP3911337A4/fr active Pending
- 2020-01-16 JP JP2021541460A patent/JP2022522991A/ja active Pending
- 2020-01-16 WO PCT/US2020/013959 patent/WO2020150531A1/fr not_active Ceased
- 2020-01-16 CA CA3127052A patent/CA3127052A1/fr active Pending
- 2020-01-16 BR BR112021014073-5A patent/BR112021014073A2/pt not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016126982A1 (fr) * | 2015-02-05 | 2016-08-11 | Marc Selner | Suspension de nano-vésicules ioniques et biocide préparé à partir d'une telle suspension |
| US20160271121A1 (en) * | 2015-03-16 | 2016-09-22 | Gavis Pharmaceuticals | Antifungal combination therapy |
| US20170333346A1 (en) * | 2015-06-19 | 2017-11-23 | Global Health Solutions Llc | Petrolatum-based delivery systems and for active ingredients |
Non-Patent Citations (1)
| Title |
|---|
| See also references of WO2020150531A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3127052A1 (fr) | 2020-07-23 |
| WO2020150531A1 (fr) | 2020-07-23 |
| EP3911337A1 (fr) | 2021-11-24 |
| JP2022522991A (ja) | 2022-04-21 |
| BR112021014073A2 (pt) | 2021-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3924481A4 (fr) | Compositions et méthodes de traitement d'hémoglobinopathies | |
| EP3959318A4 (fr) | Compositions d'oligonucléotides et leurs méthodes d'utilisation | |
| EP3920923A4 (fr) | Agents thérapeutiques et méthodes de traitement | |
| EP3965832A4 (fr) | Compositions et méthodes de traitement de l'hépatite b | |
| EP3976595A4 (fr) | Composés de 1-oxo-isoindoline-5-carboxamide substitués, compositions de ceux-ci, et procédés de traitement associés | |
| EP3775263A4 (fr) | Compositions et méthodes de traitement de l'acné | |
| EP4337203A4 (fr) | Inhibiteurs de l'interaction ménine-mll | |
| EP4319751A4 (fr) | Compositions thérapeutiques et méthodes de traitement de tumeurs | |
| EP3856214A4 (fr) | Compositions microbiennes et méthodes d'utilisation | |
| EP3843524A4 (fr) | Composition de traitement des semences et procédé d'utilisation | |
| EP4284417A4 (fr) | Compositions et méthodes de traitement de l'angi?dème héréditaire | |
| FR25C1007I1 (fr) | Formulations d'épinéphrine intranasale et méthodes de traitement d'une maladie | |
| MA55532A (fr) | Composés de neuréguline-4 et procédés d'utilisation | |
| EP4100127A4 (fr) | Méthodes de traitement de la sclérodermie et d'états associés | |
| EP3843700A4 (fr) | Compositions et méthodes de soins dentaires | |
| EP4326277A4 (fr) | Méthodes de traitement de strictions d'sophagiennes | |
| EP4232041A4 (fr) | Méthodes de traitement de tauopathies à 4 répétitions | |
| EP3996712A4 (fr) | Compositions et procédés destinés au traitement de la démence à corps de lewy | |
| EP4135760A4 (fr) | Compositions et méthodes de traitement de la leucémie | |
| EP4100430A4 (fr) | Compositions et méthodes de traitement de l'hypertension pulmonaire | |
| EP4037696A4 (fr) | Compositions et méthodes de traitement de la maladie d'alzheimer | |
| EP4384220A4 (fr) | Compositions et méthodes de traitement du cancer | |
| EP3781945A4 (fr) | Compositions et méthodes de traitement de l'endométriose | |
| EP4007610A4 (fr) | Compositions et méthodes de traitement d' alpha-thalassémie | |
| EP3911337A4 (fr) | Compositions à base de pétrolatum et méthodes de traitement de l'onychomycose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20210816 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAV | Request for validation of the european patent (deleted) | ||
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20220927 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 8/34 20060101ALI20220921BHEP Ipc: A61K 8/22 20060101ALI20220921BHEP Ipc: A61K 47/10 20170101ALI20220921BHEP Ipc: A61K 33/40 20060101AFI20220921BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20250219 |